Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Ramos Ruperto

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|February 16, 2024
CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysisRaquel Ron, Javier Martínez-Sanz, Sabina Herrera, et al.
Frontiers in Immunology|March 6, 2024
Corrigendum: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysisRaquel Ron, Javier Martínez-Sanz, Sabina Herrera, et al.
Open Forum Infectious Diseases|March 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real WorldAlejandro de Gea-Grela, Rafael Micán, Rosa de Miguel, et al.
Scientific Reports|October 21, 2024
Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIVLaura Tarancon-Diez, Itziar Carrasco, Laura Montes, et al.
The Journal of Infection|November 9, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)Juan Ambrosioni, Elisa de Lazzari, Sonsoles Sánchez-Palomino, et al.
HIV Medicine|February 21, 2024
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIVLuis Ramos-Ruperto, Maria Del Mar Arcos-Rueda, Rosa de Miguel-Buckley, et al.
AIDS and Behavior|April 4, 2025
Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as PredictorsMar J F Ollero, Pablo Ryan, Helen Dolengevich-Segal, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 1, 2023
Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIVJulia Vásquez Manau, Cristina Marcelo Calvo, Alejandro De Gea Grela, et al.
AIDS and Behavior|June 15, 2025
Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIVJoanna Cano-Smith, Ana Delgado-Hierro, Luis Ramos-Ruperto, et al.
Open Forum Infectious Diseases|November 28, 2025
Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)Pablo Ryan, Juan Berenguer, Luis Ramos-Ruperto, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 16, 2024
CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysisRaquel Ron, Javier Martínez-Sanz, Sabina Herrera, et al.
Frontiers in Immunology|March 6, 2024
Corrigendum: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysisRaquel Ron, Javier Martínez-Sanz, Sabina Herrera, et al.
Open Forum Infectious Diseases|March 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real WorldAlejandro de Gea-Grela, Rafael Micán, Rosa de Miguel, et al.
Scientific Reports|October 21, 2024
Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIVLaura Tarancon-Diez, Itziar Carrasco, Laura Montes, et al.
The Journal of Infection|November 9, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)Juan Ambrosioni, Elisa de Lazzari, Sonsoles Sánchez-Palomino, et al.
HIV Medicine|February 21, 2024
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIVLuis Ramos-Ruperto, Maria Del Mar Arcos-Rueda, Rosa de Miguel-Buckley, et al.
AIDS and Behavior|April 4, 2025
Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as PredictorsMar J F Ollero, Pablo Ryan, Helen Dolengevich-Segal, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 1, 2023
Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIVJulia Vásquez Manau, Cristina Marcelo Calvo, Alejandro De Gea Grela, et al.
AIDS and Behavior|June 15, 2025
Preparing for the Next Physician's Visit: Usability and Validity of a Mobile Health App for People Living with HIVJoanna Cano-Smith, Ana Delgado-Hierro, Luis Ramos-Ruperto, et al.
Open Forum Infectious Diseases|November 28, 2025
Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)Pablo Ryan, Juan Berenguer, Luis Ramos-Ruperto, et al.
Pageof 3